Imaging Biomarkers of Pancreatic Function and Disease
Launched by CHILDREN'S HOSPITAL MEDICAL CENTER, CINCINNATI · Dec 12, 2022
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Pancreatitis can be acute \[AP\], acute recurrent \[ARP\] (defined as two discrete attacks with interval resolution), or chronic \[CP\]. Adult studies show that up to 40% of patients develop abnormal glucose metabolism after a single attack of AP, with a 2.5x increased risk of diabetes. CP is defined, in part, by the presence of established endocrine (diabetes) or exocrine pancreatic insufficiency \[EPI\]. Currently, it is not possible to non-invasively diagnose or predict development of pancreatitis-related endocrine or exocrine insufficiency.
The investigator's data has shown that CFTR g...
Gender
ALL
Eligibility criteria
- • Aim 1-
- Patient Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Scheduled for clinically-indicated gastrointestinal endoscopy
- • Clinical diagnosis or suspicion of exocrine pancreatic insufficiency
- Exclusion Criteria:
- • Complete fatty replacement of pancreas on prior imaging
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- Control Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Scheduled for clinically-indicated gastrointestinal endoscopy
- Exclusion Criteria:
- • Sweat chloride \>60 mmol/L
- • Clinical diagnosis of gastrointestinal pathology
- • Clinical diagnosis or history of pancreatic disease
- • Complete fatty replacement of pancreas on prior imaging
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- • Aim 2-
- Acute Pancreatitis Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinically documented episode of acute pancreatitis
- Exclusion Criteria:
- • More than one episode of acute pancreatitis
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Pregnancy
- Acute Recurrent Pancreatitis Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinical diagnosis of acute recurrent pancreatitis
- Exclusion Criteria:
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Pregnancy
- Pancreatitis-Related Diabetes Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinical diagnosis of pancreatitis-related diabetes
- Exclusion Criteria:
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Pregnancy
- • Aim 3-
- Control Group:
- Inclusion Criteria:
- • • Age 5 to \<21 years
- Exclusion Criteria:
- • Sweat chloride \>60 mmol/L
- • Clinical diagnosis of gastrointestinal pathology
- • Clinical diagnosis or history of pancreatic disease, including acute pancreatitis
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- Acute Pancreatitis Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinically documented episode of acute pancreatitis
- Exclusion Criteria:
- • More than one episode of acute pancreatitis
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- Acute Recurrent Pancreatitis Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinical diagnosis of acute recurrent pancreatitis with no evidence of CP or EPI
- Exclusion Criteria:
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- Chronic Pancreatitis Group:
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Clinical diagnosis of chronic pancreatitis
- Exclusion Criteria:
- • Current acute pancreatitis or acute pancreatitis less than 30 days prior to research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- • Aim 4-
- Inclusion Criteria:
- • Age 5 to \<21 years
- • Completed research MRI under Aims 1 or 3 of this study
- Exclusion Criteria:
- • Failed/unable to complete first research MRI under Aims 1 or 3
- • Episode of acute pancreatitis since first research MRI
- • Current acute pancreatitis
- • Any gastrointestinal surgery or pancreas intervention (e.g. ERCP) since first research MRI
- • Need for sedation for MRI
- • Contraindication to MRI (implanted metal hardware)
- • Allergy to secretin
- • Pregnancy
- • Aim 5-
- Inclusion Criteria:
- • • MRI performed at CCHMC
- Exclusion Criteria:
- • Severe image artifact compromising image quality (judgement of study team)
- • Age \>21 years
About Children's Hospital Medical Center, Cincinnati
Children's Hospital Medical Center in Cincinnati is a leading pediatric healthcare institution dedicated to advancing child health through innovative clinical research and comprehensive patient care. Renowned for its commitment to excellence, the center conducts a wide range of clinical trials aimed at developing and evaluating new treatments and therapies for pediatric populations. With a focus on multidisciplinary collaboration and ethical research practices, Children's Hospital Medical Center strives to improve health outcomes for children while contributing to the broader scientific understanding of pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cincinnati, Ohio, United States
Patients applied
Trial Officials
Andrew Trout, MD
Principal Investigator
Children's Hospital Medical Center, Cincinnati
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials